Navigation Links
Tianyin Pharmaceutical Co., Inc. Announces Trading Symbol Error and Correction
Date:8/20/2008

CHENGDU, China, Aug. 20 /Xinhua-PRNewswire-FirstCall/ -- Tianyin Pharmaceutical, Co., Inc. (OTC Bulletin Board: TYNP, TYNPE), a manufacturer and supplier of modernized traditional Chinese medicine ("TCM") based in Chengdu, China, today announced that the Company's stock symbol had been inadvertently changed to OTC BB: TYNPE due to the electronic eligibility system error.

The error is being corrected immediately and the Company expects the stock symbol to trade under the symbol OTC BB: TYNP on Thursday, August 21, 2008.

Tianyin Pharmaceutical Co., Inc. is a fully-reporting company and the Company's fiscal year ends on June 30. The Company will file its 10K for FY2008 on a timely manner, which is due on September 30. The Company has been compliant is all its fillings.

"This symbol error was very unfortunate and we do wish to assure our shareholders that there is absolutely no problem with Tianyin Pharmaceutical," said Dr. Jiang, Chairman and CEO of Tianyin Pharmaceutical Co., Inc. ''We will announce earnings results for fiscal year 2008 that ended June 30, 2008 before the reporting deadline of September 30, 2008. Additionally, we would like to reiterate that the Company expects to exceed its fiscal year 2008 make good of $5.6 million in net income or fully diluted EPS of $0.16 per share.''

About Tianyin Pharmaceuticals

Tianyin is a manufacturer and supplier of modernized Traditional Chinese Medicine ("TCM") in China. It was established in 1994 and acquired by the current management team in August 2003. It has a comprehensive product portfolio of 34 modernized TCMs in the market, 22 of which are listed in the highly selective National Medicine Catalog of the National Medical Insurance Program. Tianyin owns and operates two GMP manufacturing facilities and an R&D platform supported by leading Chinese academic institutions. The Company has a pipeline of 51 pharmaceutical products pending approval. Tianyin has an extensive nationw
'/>"/>

SOURCE Tianyin Pharmaceuticals
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Viscorp, Inc. Announces Name Change to Tianyin Pharmaceutical Co Inc. and Begins Trading Under the Ticker OTC BB: TYNP
2. Tianyin Pharmaceutical to Present at Roth Third Annual China Discovery Tour in Beijing on May 20, 2008 at 12:40 p.m. Beijing Time
3. Tianyin Pharmaceutical Co., Inc. to Host Fiscal Year 2008 Third Quarter Earnings Conference Call on Thursday, May 15, 2008 at 9:00 a.m. EDT
4. Tianyin Pharmaceutical Co., Inc. Announces Third Quarter 2008 Financial Results
5. Tianyin Pharmaceutical Signs Over 60 New Distribution Agreements with 15 Regional Distributors
6. Tianyin Pharmaceutical Co., Inc. Completes Production for Earthquake
7. Tianyin Pharmaceutical Co., Inc. Receives Chinese SFDA Approval for Simvastatin Tablets
8. Mylan Commences Tender Offers and Consent Solicitations for Its 5.750% Senior Notes Due 2010 and 6.375% Senior Notes Due 2015 in Connection With Its Proposed Acquisition of Mercks Generic Pharmaceutical Business
9. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
10. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
11. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/1/2015)... ... August 01, 2015 , ... Brig and Lita Hart, icons ... the unification of their Healthy Home mission with the HOPE Movement of EvolvHealth. In ... founders of both companies have agreed to join their missions of purpose together to ...
(Date:8/1/2015)... ... August 01, 2015 , ... “ reTXT ” was featured on NewsWatch ... coolest applications on the market for iOS, Android, and Windows. Joe Toohey, the host ... users to clarify, edit and delete any message including ones already sent. , While ...
(Date:7/31/2015)... ... August 01, 2015 , ... The Honor Society of Nursing, ... on the Future of Nursing (GAPFON) 20-21 July 2015 in San Juan, Puerto Rico. ... this meeting. , Dr. Silvia Cassiani, Advisor, Nursing and Allied Health Personnel Development, Unit ...
(Date:7/31/2015)... Alexandria, VA (PRWEB) , ... July 31, 2015 ... ... Foundation) introduced its new store run by GoodThreads. The store can be accessed ... products and designs, many of which are customizable. The best part: whenever a ...
(Date:7/31/2015)... (PRWEB) , ... July 31, 2015 , ... ... communicate. Rally Insurance Group, Inc. has re-branded their social media profiles to better ... personal way for consumers to communicate, find information, share insights and opinions. The ...
Breaking Medicine News(10 mins):Health News:Looking for HOPE? Healthy Home Has Evolv’d 2Health News:Looking for HOPE? Healthy Home Has Evolv’d 3Health News:Correct Auto-Correct and Clarify the Unclear with reTXT Messaging App 2Health News:Key Latin American Nurse Leaders Identify Regional Issues During Global Advisory Panel on the Future of Nursing Meeting 2Health News:Key Latin American Nurse Leaders Identify Regional Issues During Global Advisory Panel on the Future of Nursing Meeting 3Health News:Key Latin American Nurse Leaders Identify Regional Issues During Global Advisory Panel on the Future of Nursing Meeting 4Health News:Mesothelioma Organization Launches New Store 2Health News:Mesothelioma Organization Launches New Store 3Health News:Rally Insurance Group, Inc. Connects to Customers Through Re-branded Social Media Profiles 2
... University of California, Berkeley, and Chilean researchers says that children ... water are more likely to succumb to lung cancer or ... adult life. ,It was found that the risk ... if the child's mother also drank the arsenic-contaminated water during ...
... affecting about 1% of the female population. Women with heavy ... undetected. Only about 5,000 women have been diagnosed in the ... for the Haemophilia Society says that about only 70% approach ... is a condition which leads to heavy or prolonged menstrual ...
... in Europe, reports a league table, to be published before ... of the treatment and encourages childless women to take part ... , When compared to the success rates of ... to attain a success rate of 28.6%. this is a ...
... Phobia is an anxiety disorder characterised by extreme and irrational ... know exactly what causes this. // ,To overcome ... in the trial stage. ,The remedy developed by ... which the body produces naturally in times of stress or ...
... patients should be given a set of legally-binding entitlements ... standards in the cancer services would help to avoid ... National Institute of Health and Clinical Excellence (Nice). ... would be standardized should include home care, appraisal of ...
... by almost two times since 1990 in America. Labor, delivery ... being increasingly manipulated to suit the whims and fancies of ... fan in Pittsburg told news reporters that she requested her ... not miss the game. After determining the safety of the ...
Cached Medicine News:Health News:Arsenic in Drinking Water Predisposes Children To Lung Cancer in Later Life 2Health News:British fertility clinics have low success rates 2Health News:To Wait Or Not 2
(Date:7/31/2015)... and SAN DIEGO , ... its parent company Eisai Co., Ltd. (Headquarters: ... , "Eisai") and Halozyme Therapeutics, Inc. (Headquarters: ... Helen Torley , "NASDAQ: HALO") have signed a ... name: Halaven ® , "eribulin") in combination with Halozyme,s ...
(Date:7/31/2015)... 31, 2015 Magnaquest, a ... data and cloud computing operators has signed a ... giant for Internet of Things (IoT) related initiative. ... on subscription model.      (Logo: ... striving for business innovations to make healthcare services ...
(Date:7/30/2015)... July 30, 2015  ResMed (NYSE: ... a definitive agreement to acquire Curative Medical, ... and sleep-disordered breathing medical devices and accessories. ... in China, combined with ResMed,s global leadership in sleep and respiratory ... China suffering from sleep-disordered ...
Breaking Medicine Technology:Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer 2Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer 3Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer 4Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer 5Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer 6Magnaquest Signs a POC With a Leading Pharma Giant in Europe to Manage Subscription Management and Billing for Internet of Things (IoT) 2ResMed Invests in High-Growth Chinese Sleep and Respiratory Care Market with Curative Medical 2ResMed Invests in High-Growth Chinese Sleep and Respiratory Care Market with Curative Medical 3
... ... 17-20, Currently, over 54,255 Trials with Locations in 154 Countries Are Taking ... ... Board (IRB), is,responsible for overseeing research and protecting the rights and welfare,of people participating in ...
... international lymphoma conference shows, investigational regimen resulted in 82 percent overall survival ... ... III clinical trial is presently being conducted in this ... patient population, LUGANO, Switzerland, June 9 ...
Cached Medicine Technology:ASPIRE Independent Review Board Announces 10 Ways to Protect Participants' Rights in Clinical Drug Trials and Optimize Results From Research 2ASPIRE Independent Review Board Announces 10 Ways to Protect Participants' Rights in Clinical Drug Trials and Optimize Results From Research 3Sequential R-CHOP and Ibritumomab Tiuxetan (Zevalin(R)) Regimen Produces Impressive Survival Rates in High Risk Elderly Patients With Untreated Aggressive Diffuse Large B-cell Lymphoma 2Sequential R-CHOP and Ibritumomab Tiuxetan (Zevalin(R)) Regimen Produces Impressive Survival Rates in High Risk Elderly Patients With Untreated Aggressive Diffuse Large B-cell Lymphoma 3Sequential R-CHOP and Ibritumomab Tiuxetan (Zevalin(R)) Regimen Produces Impressive Survival Rates in High Risk Elderly Patients With Untreated Aggressive Diffuse Large B-cell Lymphoma 4
... autoLog™ Autotransfusion System processes blood collected ... washed red blood cells for return ... time. This is achieved with only ... innovative bowl design, coupled with sophisticated ...
The hipGRIP® is a twenty piece modular lateral positioning system which provides positive pelvis control with an innovative positioning system....
The Simpulse®VariCare™ System provides an innovative system for enhanced wound management which emphasizes performance, simplicity, safety, value, and support....
... staples are especially useful in ... including anterior cruciate reconstruction. They ... fixation, tendon and ligament repair ... Four sizes are available, in ...
Medicine Products: